InsidersTradesSigma
Track the ImmuneOnco Biopharmaceuticals (Shanghai) Inc. - B share price and the full directors' dealings record of the company, a publicly traded company based in Hong Kong. Shares are quoted on the HK market, under the oversight of HKEX. Operating in the Health Care sector, ImmuneOnco Biopharmaceuticals (Shanghai) Inc. - B has logged 1 insider filings. Market capitalisation: €1.4bn. The latest transaction was disclosed on 14 May 2026 (Purchase). Among the most active insiders: Tian Wenzhi. Every trade is openly available.
1
Insider Decl.
n/a
Thresholds
€21,094
1 ops.
Buy Volume
n/a
n/a
Sell Volume
23Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,866 of 28,855 companies
34.0
score / 100
Value14
Quality54
FCF yld-13%
Earn yld-14%
EV/EBITDA·
ROE-30%
Gross mgn99%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 14 May 2026
Declarations1 total
50,000 shares@ HK$3.870.011% mcap100.0% of flowShareXHKGHKEX:DA20260513E00577
1 of 1 declaration
About ImmuneOnco Biopharmaceuticals (Shanghai) Inc. - B
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. is a company focused on developing innovative treatments in oncology. It is listed on the XHKG market.